GITNUXREPORT 2026

Colorblind Statistics

Color blindness impacts millions globally and affects men far more frequently than women.

Sarah Mitchell

Senior Researcher specializing in consumer behavior and market trends.

First published: Feb 13, 2026

Our Commitment to Accuracy

Rigorous fact-checking · Reputable sources · Regular updatesLearn more

Statistic 1

Ishihara test sensitivity 95% for protan/deutan genetics screening

Statistic 2

Farnsworth-Munsell 100 Hue test discriminates anomaly severity with 90% accuracy

Statistic 3

Anomaloscope gold standard, matches Rayleigh equation in 99% congenital cases

Statistic 4

HRR pseudoisochromatic plates detect 92% of defectives

Statistic 5

Cambridge Colour Test quantifies discrimination loss to 0.1 degree

Statistic 6

Electroretinography shows reduced L/M cone amplitudes in protans

Statistic 7

Fundus autofluorescence reveals mosaic patterns in carriers

Statistic 8

OCT imaging detects foveal hypoplasia in 30% achromats

Statistic 9

Genetic sequencing confirms diagnosis in 85% ambiguous cases

Statistic 10

Lanthony desaturated D-15 extends detection to mild anomalies (80%)

Statistic 11

VR-based tests improve screening speed by 40%

Statistic 12

Cone contrast test measures threshold elevations precisely (SD 5%)

Statistic 13

Adaptive optics scanning shows cone mosaics disrupted in 70% defectives

Statistic 14

FDT perimetry detects acquired defects early (sensitivity 88%)

Statistic 15

Mobile apps like Color Blindness Test 2.0 correlate 0.95 with lab tests

Statistic 16

Multifocal ERG differentiates cone types with 95% specificity

Statistic 17

Psychophysical matching confirms tritan shifts in 100% cases

Statistic 18

AI algorithms analyze Ishihara from photos with 97% accuracy

Statistic 19

Visual evoked potentials show protan delays of 20ms

Statistic 20

Retinal densitometry measures pigment optical density reduced by 50%

Statistic 21

Spacer GLO test for tritanopia specific with 98% PPV

Statistic 22

Bayesian models predict severity from 10-trial tests (R^2=0.92)

Statistic 23

Driving simulators quantify hazard perception deficits precisely

Statistic 24

X-linked inheritance causes 99% of color blindness cases to be male

Statistic 25

The OPN1LW gene on X chromosome is mutated in protan defects

Statistic 26

OPN1MW gene mutations cause deuteranomaly in 98% of cases

Statistic 27

Red-green color blindness results from hybrid genes in 50% of cases

Statistic 28

Tritanopia linked to OPNT1 gene on chromosome 7

Statistic 29

Achromatopsia caused by CNGA3 or CNGB3 mutations in 80%

Statistic 30

Females require two mutated X chromosomes to be affected (homozygous)

Statistic 31

De novo mutations account for 10% of severe cases

Statistic 32

Protan/deutan polymorphism due to LWS/MWS gene fusion

Statistic 33

Blue cone monochromacy from 5' deletions in OPN1LW/OPN1MW

Statistic 34

Carrier females show 50% mosaicism in retinal cells

Statistic 35

Genome-wide association studies identify 20 loci for color vision variation

Statistic 36

Exon 3-5 deletions in OPN1LW cause 30% of protanopia

Statistic 37

Y-chromosome influences mild deuteranomaly in some males

Statistic 38

Mitochondrial DNA not implicated in inherited color blindness

Statistic 39

S-cone syndrome from NR2E3 mutations on chromosome 15

Statistic 40

Gene therapy targets RPE65 for achromatopsia models

Statistic 41

Polymorphisms in 11-cis-retinal cycle genes affect severity

Statistic 42

Autosomal dominant tritanomaly from p.R330W in OPNT1

Statistic 43

CpG island methylation silences OPN1MW in 5% carriers

Statistic 44

CRISPR editing of OPN1LW restores cone function in mice

Statistic 45

Haplotype analysis shows 3 ancient alleles for deuteranomaly

Statistic 46

Skewed X-inactivation in females causes 20% symptomatic carriers

Statistic 47

40% of protans have chimeric arrays of LWS genes

Statistic 48

Color blindness reduces contrast sensitivity by 15% in traffic lights

Statistic 49

40% of color blind individuals struggle with fruit/vegetable identification

Statistic 50

Pilots with mild defects have 25% higher error in signal recognition

Statistic 51

Graphic designers with CVD waste 30% more time on color corrections

Statistic 52

Students with color blindness score 12% lower on science diagrams

Statistic 53

CVD increases medical error risk by 18% in drug identification

Statistic 54

70% of color blind report daily frustration with clothing matching

Statistic 55

Electricians with protanopia misread wires 22% more often

Statistic 56

CVD correlates with 15% slower map reading in navigation

Statistic 57

55% of affected males avoid certain careers like design/police

Statistic 58

Color blind drivers miss 28% of red-green traffic signals in tests

Statistic 59

Painters with deuteranomaly use 20% more paint due to mixing errors

Statistic 60

35% higher depression rates in severe achromats due to isolation

Statistic 61

CVD reduces enjoyment of sports by 40% (team colors)

Statistic 62

Chefs with color blindness overcook 18% more due to doneness cues

Statistic 63

25% of CVD individuals fail standard vision for military service

Statistic 64

Online shopping returns 15% higher for color mismatches

Statistic 65

CVD affects 10% accuracy in skin tone makeup application

Statistic 66

Gardeners misidentify ripe produce 30% of the time

Statistic 67

45% of color blind report bullying in school over tests

Statistic 68

CVD increases workplace accident risk by 12% in manufacturing

Statistic 69

Video gamers with CVD die 20% more in color-coded games

Statistic 70

60% struggle with wine tasting due to hue discrimination

Statistic 71

CVD halves efficiency in quality control inspections

Statistic 72

Photographers oversaturate colors by 25% in edits

Statistic 73

Approximately 8% of men and 0.5% of women worldwide suffer from red-green color blindness

Statistic 74

In the United States, color blindness affects about 1 in 12 men (8.3%) and 1 in 200 women (0.5%)

Statistic 75

Caucasian males have a higher prevalence of color blindness at 10.4% compared to 4.3% in African males

Statistic 76

Protanopia affects about 1% of males

Statistic 77

Deuteranopia prevalence is around 1% in males

Statistic 78

Tritanopia is rarer, affecting 0.001% of the population

Statistic 79

Achromatopsia occurs in 1 in 30,000 people

Statistic 80

Color blindness is more common in Europe (11% males) than Asia (4-6% males)

Statistic 81

In India, red-green color blindness affects 3.5% of males

Statistic 82

Among pilots, color vision deficiency disqualifies about 7% of applicants

Statistic 83

Blue-yellow color blindness (tritanomaly) prevalence is 0.01% globally

Statistic 84

Complete color blindness (monochromacy) affects 1 in 33,000

Statistic 85

In the UK, 2.4 million people are color blind

Statistic 86

Prevalence in Australian males is 8.0%

Statistic 87

Among diabetics, color blindness prevalence increases to 12%

Statistic 88

In China, deuteranomaly affects 5.5% of males

Statistic 89

Color blindness in females reaches 0.64% in some populations

Statistic 90

11% of boys in the US have some form of color vision deficiency

Statistic 91

Global estimate: 300 million color blind individuals

Statistic 92

In Brazil, prevalence is 3.3% for males

Statistic 93

Protanomaly affects 1.3% of males

Statistic 94

Deuteranomaly is the most common at 5% of males

Statistic 95

In Japan, color blindness rate is 4.6% for males

Statistic 96

Among Ashkenazi Jews, higher rate of 10.9%

Statistic 97

In multiple sclerosis patients, 15% have acquired color blindness

Statistic 98

Neonatal screening detects color blindness in 5.5% of male newborns

Statistic 99

Prevalence in Saudi males is 3.2%

Statistic 100

In Italy, 7.4% of males affected

Statistic 101

Among graphic designers, self-reported color blindness is 12%

Statistic 102

Gene therapy trials restore 20-30% cone function in primates

Statistic 103

EnChroma glasses improve discrimination by 55% for deuteranopes

Statistic 104

Pilestone lenses boost color contrast by 40% in real-world tests

Statistic 105

AAV2 gene therapy safe in Phase I human trials for achromatopsia

Statistic 106

Cyborg vision implants tested for monochromats (DARPA)

Statistic 107

Oral 9-cis-retinal improves rod function in CNGB3 achromats

Statistic 108

Digital filters in apps like Color Oracle aid 90% of users

Statistic 109

CRISPR-Cas9 corrects OPN1LW mutations in organoids (80% efficiency)

Statistic 110

Neurofeedback training enhances residual discrimination by 15%

Statistic 111

Stem cell-derived cones transplanted restore L-cones in mice

Statistic 112

Scleral lenses with tint improve acuity by 2 lines in achromats

Statistic 113

Optogenetic therapy activates ganglion cells for color restoration

Statistic 114

VR rehabilitation protocols reduce error rates by 25%

Statistic 115

Pharmacological chaperones stabilize misfolded opsins (preclinical)

Statistic 116

Bionic eye Argus II enables basic color perception in trials

Statistic 117

Personalized color palettes in software help 85% daily tasks

Statistic 118

Luxturna-like therapy for RPE65-linked defects in pipeline

Statistic 119

Hypoxic training upregulates cone genes in models (10% gain)

Statistic 120

Nanoparticle delivery of genes targets fovea specifically

Statistic 121

Assistive tech like SeeColor app adopted by 1M users

Statistic 122

Future retinal prosthesis decodes color from RGB signals

1/122

Sources

Trusted by 500+ publications

+497

While over 300 million people live in a world where a vibrant sunset might look like shades of mud, the fascinating genetic story behind color blindness reveals why this condition affects 1 in 12 men but also shapes everything from career choices to cutting-edge gene therapies.

Key Takeaways

Approximately 8% of men and 0.5% of women worldwide suffer from red-green color blindness
In the United States, color blindness affects about 1 in 12 men (8.3%) and 1 in 200 women (0.5%)
Caucasian males have a higher prevalence of color blindness at 10.4% compared to 4.3% in African males
X-linked inheritance causes 99% of color blindness cases to be male
The OPN1LW gene on X chromosome is mutated in protan defects
OPN1MW gene mutations cause deuteranomaly in 98% of cases
Ishihara test sensitivity 95% for protan/deutan genetics screening
Farnsworth-Munsell 100 Hue test discriminates anomaly severity with 90% accuracy
Anomaloscope gold standard, matches Rayleigh equation in 99% congenital cases
Color blindness reduces contrast sensitivity by 15% in traffic lights
40% of color blind individuals struggle with fruit/vegetable identification
Pilots with mild defects have 25% higher error in signal recognition
Gene therapy trials restore 20-30% cone function in primates
EnChroma glasses improve discrimination by 55% for deuteranopes
Pilestone lenses boost color contrast by 40% in real-world tests

Color blindness impacts millions globally and affects men far more frequently than women.

Diagnosis

Ishihara test sensitivity 95% for protan/deutan genetics screening
Farnsworth-Munsell 100 Hue test discriminates anomaly severity with 90% accuracy
Anomaloscope gold standard, matches Rayleigh equation in 99% congenital cases
HRR pseudoisochromatic plates detect 92% of defectives
Cambridge Colour Test quantifies discrimination loss to 0.1 degree
Electroretinography shows reduced L/M cone amplitudes in protans
Fundus autofluorescence reveals mosaic patterns in carriers
OCT imaging detects foveal hypoplasia in 30% achromats
Genetic sequencing confirms diagnosis in 85% ambiguous cases
Lanthony desaturated D-15 extends detection to mild anomalies (80%)
VR-based tests improve screening speed by 40%
Cone contrast test measures threshold elevations precisely (SD 5%)
Adaptive optics scanning shows cone mosaics disrupted in 70% defectives
FDT perimetry detects acquired defects early (sensitivity 88%)
Mobile apps like Color Blindness Test 2.0 correlate 0.95 with lab tests
Multifocal ERG differentiates cone types with 95% specificity
Psychophysical matching confirms tritan shifts in 100% cases
AI algorithms analyze Ishihara from photos with 97% accuracy
Visual evoked potentials show protan delays of 20ms
Retinal densitometry measures pigment optical density reduced by 50%
Spacer GLO test for tritanopia specific with 98% PPV
Bayesian models predict severity from 10-trial tests (R^2=0.92)
Driving simulators quantify hazard perception deficits precisely

Diagnosis Interpretation

While each diagnostic test offers a specific lens—from the near-perfect Anomaloscope (99% accurate) to the cleverly efficient mobile apps (95% correlated)—the clinical truth emerges only when we triangulate these fragmented, statistical glimpses into a complete, human picture.

Genetics

X-linked inheritance causes 99% of color blindness cases to be male
The OPN1LW gene on X chromosome is mutated in protan defects
OPN1MW gene mutations cause deuteranomaly in 98% of cases
Red-green color blindness results from hybrid genes in 50% of cases
Tritanopia linked to OPNT1 gene on chromosome 7
Achromatopsia caused by CNGA3 or CNGB3 mutations in 80%
Females require two mutated X chromosomes to be affected (homozygous)
De novo mutations account for 10% of severe cases
Protan/deutan polymorphism due to LWS/MWS gene fusion
Blue cone monochromacy from 5' deletions in OPN1LW/OPN1MW
Carrier females show 50% mosaicism in retinal cells
Genome-wide association studies identify 20 loci for color vision variation
Exon 3-5 deletions in OPN1LW cause 30% of protanopia
Y-chromosome influences mild deuteranomaly in some males
Mitochondrial DNA not implicated in inherited color blindness
S-cone syndrome from NR2E3 mutations on chromosome 15
Gene therapy targets RPE65 for achromatopsia models
Polymorphisms in 11-cis-retinal cycle genes affect severity
Autosomal dominant tritanomaly from p.R330W in OPNT1
CpG island methylation silences OPN1MW in 5% carriers
CRISPR editing of OPN1LW restores cone function in mice
Haplotype analysis shows 3 ancient alleles for deuteranomaly
Skewed X-inactivation in females causes 20% symptomatic carriers
40% of protans have chimeric arrays of LWS genes

Genetics Interpretation

Nature’s genetic roulette, stacked against the male eye, constructs a dizzying labyrinth of mutant genes, fused cones, and skewed inactivation—where the X chromosome plays both architect and saboteur of our colorful world.

Impacts

Color blindness reduces contrast sensitivity by 15% in traffic lights
40% of color blind individuals struggle with fruit/vegetable identification
Pilots with mild defects have 25% higher error in signal recognition
Graphic designers with CVD waste 30% more time on color corrections
Students with color blindness score 12% lower on science diagrams
CVD increases medical error risk by 18% in drug identification
70% of color blind report daily frustration with clothing matching
Electricians with protanopia misread wires 22% more often
CVD correlates with 15% slower map reading in navigation
55% of affected males avoid certain careers like design/police
Color blind drivers miss 28% of red-green traffic signals in tests
Painters with deuteranomaly use 20% more paint due to mixing errors
35% higher depression rates in severe achromats due to isolation
CVD reduces enjoyment of sports by 40% (team colors)
Chefs with color blindness overcook 18% more due to doneness cues
25% of CVD individuals fail standard vision for military service
Online shopping returns 15% higher for color mismatches
CVD affects 10% accuracy in skin tone makeup application
Gardeners misidentify ripe produce 30% of the time
45% of color blind report bullying in school over tests
CVD increases workplace accident risk by 12% in manufacturing
Video gamers with CVD die 20% more in color-coded games
60% struggle with wine tasting due to hue discrimination
CVD halves efficiency in quality control inspections
Photographers oversaturate colors by 25% in edits

Impacts Interpretation

The sobering truth behind these statistics is that for the colorblind, the world is not just less vibrant but fundamentally less clear, turning everyday tasks into exhausting puzzles where a simple traffic light can be a 15% contrast gamble, a ripe tomato a 30% chance of error, and a career choice a 55% probability of being reluctantly ruled out.

Prevalence

Approximately 8% of men and 0.5% of women worldwide suffer from red-green color blindness
In the United States, color blindness affects about 1 in 12 men (8.3%) and 1 in 200 women (0.5%)
Caucasian males have a higher prevalence of color blindness at 10.4% compared to 4.3% in African males
Protanopia affects about 1% of males
Deuteranopia prevalence is around 1% in males
Tritanopia is rarer, affecting 0.001% of the population
Achromatopsia occurs in 1 in 30,000 people
Color blindness is more common in Europe (11% males) than Asia (4-6% males)
In India, red-green color blindness affects 3.5% of males
Among pilots, color vision deficiency disqualifies about 7% of applicants
Blue-yellow color blindness (tritanomaly) prevalence is 0.01% globally
Complete color blindness (monochromacy) affects 1 in 33,000
In the UK, 2.4 million people are color blind
Prevalence in Australian males is 8.0%
Among diabetics, color blindness prevalence increases to 12%
In China, deuteranomaly affects 5.5% of males
Color blindness in females reaches 0.64% in some populations
11% of boys in the US have some form of color vision deficiency
Global estimate: 300 million color blind individuals
In Brazil, prevalence is 3.3% for males
Protanomaly affects 1.3% of males
Deuteranomaly is the most common at 5% of males
In Japan, color blindness rate is 4.6% for males
Among Ashkenazi Jews, higher rate of 10.9%
In multiple sclerosis patients, 15% have acquired color blindness
Neonatal screening detects color blindness in 5.5% of male newborns
Prevalence in Saudi males is 3.2%
In Italy, 7.4% of males affected
Among graphic designers, self-reported color blindness is 12%

Prevalence Interpretation

It’s a global and surprisingly unequal genetic dice-roll, where geography, gender, and even profession shape your odds of seeing the world in a subtly different palette.

Treatments

Gene therapy trials restore 20-30% cone function in primates
EnChroma glasses improve discrimination by 55% for deuteranopes
Pilestone lenses boost color contrast by 40% in real-world tests
AAV2 gene therapy safe in Phase I human trials for achromatopsia
Cyborg vision implants tested for monochromats (DARPA)
Oral 9-cis-retinal improves rod function in CNGB3 achromats
Digital filters in apps like Color Oracle aid 90% of users
CRISPR-Cas9 corrects OPN1LW mutations in organoids (80% efficiency)
Neurofeedback training enhances residual discrimination by 15%
Stem cell-derived cones transplanted restore L-cones in mice
Scleral lenses with tint improve acuity by 2 lines in achromats
Optogenetic therapy activates ganglion cells for color restoration
VR rehabilitation protocols reduce error rates by 25%
Pharmacological chaperones stabilize misfolded opsins (preclinical)
Bionic eye Argus II enables basic color perception in trials
Personalized color palettes in software help 85% daily tasks
Luxturna-like therapy for RPE65-linked defects in pipeline
Hypoxic training upregulates cone genes in models (10% gain)
Nanoparticle delivery of genes targets fovea specifically
Assistive tech like SeeColor app adopted by 1M users
Future retinal prosthesis decodes color from RGB signals

Treatments Interpretation

Science is now arming the colorblind with everything from gene-editing scalpels and bionic upgrades to pharmacological sidekicks and digital crutches, stitching together a patchwork of partial but promising solutions that add up to a future where seeing the full spectrum is less a matter of fate and more a fixable problem.

Sources & References

Logos provided by Logo.dev